Caseflicks

Supreme Court of New Jersey • 1984

Evers v. Dollinger

471 A.2d 405 | 95 N.J. 399 | 1984 N.J. LEXIS 2395

Full access

Unlock the video and quiz

The written brief is free to read below. Subscribe to watch the video explainer and take the quiz.

Takeaway

In short, this case holds that a delayed cancer diagnosis can support malpractice damages for tumor growth and resulting emotional distress, and that when recurrence later occurs, proof that negligence increased its risk can satisfy causation if the increased risk was a substantial factor in producing the harm.

Background

Merle Evers told Dr. Kenneth Dollinger, her gynecologist, in March 1977 that she had felt a small, painful lump in her right breast. After what he described as a complete examination, Dollinger told her he found nothing and instructed her to stop worrying. Over the next seven months, the lump grew to about four times its original size, became painful, and was accompanied by a bleeding sore. Another doctor in Dollinger's practice initially treated the sore as an abscess.

Evers sought an outside consultation in October 1977. Tests raised suspicion of cancer, and she underwent a right extended mastectomy days later. The removed 1.5-centimeter tumor was infiltrating ductal carcinoma. At the 1981 trial, the evidence indicated no detected metastasis or recurrence. While the appeal was pending, however, Evers represented that cancer cells had been found in her lung and that the cancer had metastasized.

Evers sued Dollinger and his medical group for negligent failure to diagnose and promptly treat the cancer. She did not claim that earlier diagnosis would have avoided a mastectomy. Instead, she claimed that the seven-month delay allowed the tumor to grow, caused emotional suffering, and increased the risk of recurrence and distant spread. Her experts testified that the cancer was present in March, grew during the delay, and that delay increased recurrence risk, but initially could not quantify the amount of the increased risk.

At the close of Evers's case, the trial court entered judgment for the defendants under Rule 4:40-1. Although it concluded that the evidence could support a finding of negligent deviation from medical standards, it held that Evers had not proved damages proximately caused by the negligence because she had not shown, to a reasonable medical probability, that she would fall within the group of patients whose cancer recurs. The Appellate Division affirmed. The Supreme Court of New Jersey reversed and remanded for a new trial.

Issues

Issue #1

Whether a negligently delayed cancer diagnosis can cause compensable physical injury when the patient would have needed the same surgery even with prompt diagnosis.

Holding

Yes. The growth of a malignant tumor during the negligent delay, and potentially its infiltration into surrounding tissue, are actionable physical injuries.

Reasoning

Because the case was dismissed at the close of Evers's evidence, the Court had to treat her proofs as true and draw all reasonable inferences in her favor. Those proofs established that the malignant tumor was present when Dollinger examined her in March, grew substantially during the seven-month delay, and was later identified as infiltrating ductal carcinoma.

The fact that Evers would have required a mastectomy even with timely diagnosis did not eliminate injury from delay. Dollinger's alleged failure to diagnose left the malignancy in her body longer, allowing it to remain, grow, and spread into previously healthy tissue. A larger malignant tumor meant that Evers was more seriously diseased, which was itself compensable harm.

The Court relied in part on authority recognizing that even an increase in tumor size may satisfy the injury element in a cancer-malpractice action. Here, the evidence showed not an imperceptible increase but significant growth. The trial court therefore erred by treating the absence of proof that delay caused a later recurrence as fatal to the entire damages claim.

Issue #2

Whether Evers could recover for mental and emotional suffering arising from the delayed diagnosis and treatment.

Holding

Yes. She could seek damages for emotional distress caused by the negligent delay, including anxiety over the tumor's growth and fear of the consequences of the increased risk.

Reasoning

Evers's complaint, interrogatory answers, and trial testimony supplied a basis for emotional-distress damages. She described continuing anxiety as the untreated lump enlarged, as well as insomnia, fatigue, weight gain, stress-related symptoms, anger, and fear after learning that she had cancer and that treatment had been delayed.

Mental and emotional suffering is a recognized form of compensable injury in New Jersey medical-malpractice law. The Court stressed that this distress need not be dismissed merely because Evers could not prove that the delay caused every ultimate physical consequence of her cancer.

A jury could compensate distress attributable to the delay itself: the worsening tumor, the period in which proper treatment was withheld, and the reasonable fear that the delay had made recurrence or fatal spread more likely. On remand, Evers was entitled to present evidence fully on these damages.

Issue #3

Whether, once Evers's cancer allegedly recurred, she could prove causation by showing that the negligent delay increased the risk of recurrence or distant spread and that the increased risk was a substantial factor in producing the actual harm.

Holding

Yes. In this medical-malpractice setting, Restatement (Second) of Torts § 323(a) applies: proof that negligent treatment increased the risk of the harm that actually occurred may permit a jury to find that the increased risk was a substantial factor in causing that harm.

Reasoning

The Court recognized that delayed-diagnosis cases create unusual causal uncertainty. The physician's negligence is alleged to have failed to protect the patient from a disease process already threatening her, and it is often impossible to reconstruct with conventional certainty what would have happened with timely care. Requiring proof that the eventual harm probably would not have occurred but for the delay could improperly insulate negligent providers.

Following decisions such as Hamil v. Bashline, Gradel v. Inouye, and Jones v. Montefiore Hospital, the Court adopted a more flexible causation rule. If Evers could show within a reasonable degree of medical probability that Dollinger's seven-month delay increased the risk of recurrence or distant spread, and if the feared harm in fact occurred, the jury could decide whether that increased risk was a substantial factor in producing her condition.

Restatement § 323(a) supports this approach because one who undertakes services necessary for another's protection may be liable for physical harm resulting from negligent performance when the negligence increased the risk of that harm. The Court therefore directed that, on remand, Evers may present evidence that the delay increased her risk of recurrence or metastasis and that the increased risk substantially contributed to the cancer recurrence allegedly discovered during the appeal.

Issue #4

Whether an unquantified increased risk of future cancer recurrence, standing alone and without an actual recurrence, is independently compensable.

Holding

The Court did not decide the question.

Reasoning

Evers had already shown independently actionable physical injuries—the tumor's growth and possible increased infiltration—and a basis for emotional-distress damages. In addition, the alleged recurrence during the appeal meant that the risked harm could be litigated as an actual condition under the substantial-factor framework.

Accordingly, the Court reserved for a future case whether a certain but unquantifiable increase in risk, without subsequent recurrence or other realized harm, is itself a sufficient injury to support a malpractice claim.

Concurrences

Justice Handler

Reasoning

Justice Handler agreed that Evers was entitled to a new trial because her evidence established physical injury from tumor growth and infiltration, as well as emotional injury from the delayed diagnosis. He also fully joined the Court's acceptance of Restatement § 323(a) for proving causation when an increased risk contributes substantially to harm that later occurs.

He wrote separately because he would go further than the Court. In his view, the post-trial recurrence was newly discovered evidence that independently justified a new trial under Rule 4:50-1(b), not merely a development that made the Court's increased-risk analysis relevant on remand. A clinically undetectable cancer recurrence could not reasonably have been discovered at the original trial and was directly relevant to damages.

More fundamentally, Justice Handler would recognize an actual but unquantifiable increase in the risk of recurrence as compensable injury even before a recurrence occurs. He reasoned that medical science may be unable to calculate the precise added percentage of risk, but it can reliably establish that delayed treatment makes metastasis and recurrence more likely. The inability to quantify the loss should not allow the negligent physician to escape responsibility.

In his view, the plaintiff should need to show that she faced a baseline recurrence risk and that malpractice probably increased that risk. The jury could then assess damages despite the absence of an exact numerical measure. Requiring cancer patients to wait for recurrence before suing for an already increased peril was, he concluded, unfair and could force multiple lawsuits arising from one negligent act.